Figure - available via license: Creative Commons Attribution 4.0 International
Content may be subject to copyright.
Physician and nurse characteristics
Source publication
Background
Adjuvant immunotherapy is revolutionising care for patients with resected stage III and IV melanoma. However, immunotherapy may be associated with toxicity, making treatment decisions complicated. This study aimed to identify factors physicians and nurses considered regarding adjuvant immunotherapy for melanoma.
Methods
In-depth intervie...
Context in source publication
Context 1
... half the sample managed ve or more new resected stage III patients per month who could be eligible for adjuvant immunotherapy. Most participants (80%) considered adjuvant immunotherapy trials for their patients with stage II melanoma (Table 1). A standardised questionnaire collected sociodemographic data (Additional le 1). ...Similar publications
Background
Adjuvant immunotherapy is revolutionising care for patients with resected stage III and IV melanoma. However, immunotherapy may be associated with toxicity, making treatment decisions complicated. This study aimed to identify factors physicians and nurses considered regarding adjuvant immunotherapy for melanoma.
Methods
In-depth intervi...
